RecruitingNCT06266715
ATP or saline added to escitalopram for depression
About this title
Read the official source — NCT06266715Medication studyAges 18–65China
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- GuangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 4, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- Nanfang Hospital, Southern Medical University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06266715
- Official title
Show the full official title
A Double-blind Randomized Controlled Trial of Adenosine Disodium Triphosphate in Improving Moderate to Severe Depressions
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Guangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nanfang Hospital, Southern Medical University, a university.
Does this study involve medication?
Yes. The study involves medication, including ATP Group.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
